Aleve
Coverage of Aleve in the Nexus archive.
- FDA approves new over-the-counter pain reliever that combines Tylenol and Naproxen
The FDA approved a new over-the-counter pain reliever combining acetaminophen (Tylenol) and naproxen (Aleve) into a single tablet, offering up to 12 hours of relief for common conditions like headaches and back pain. The medication provides faster and longer-lasting relief than either drug alone but carries risks such as liver damage from acetaminophen and NSAID-related complications from naproxen. Doctors advise careful label reading to avoid overdosing and recommend consulting healthcare providers for those with certain health conditions.
- FDA approves new over-the-counter pain reliever that combines Tylenol and naproxen
The FDA approved the first over-the-counter medication combining acetaminophen (Tylenol) and naproxen (Aleve) into a single tablet for up to 12 hours of pain relief. The combination aims to provide faster and longer-lasting relief for conditions like headaches, back pain, and menstrual cramps, though it carries risks such as liver damage from acetaminophen and NSAID-related complications.
- FDA approves over-the-counter pill that combines Tylenol with naproxen
The FDA approved an over-the-counter pill combining 650mg of Tylenol (acetaminophen) and 220mg of naproxen sodium for temporary pain relief. The tablet is available for adults and children 12+ and offers 12-hour pain control, with Kenvue securing a three-year exclusivity period for the formulation.
- FDA approves new pill that combines active ingredients of Tylenol and Aleve
The FDA approved a new pill that combines the active ingredients of Tylenol and Aleve. The pill was approved on Friday and is designed to merge the pain-relieving properties of both medications.